$IMCR

$31.96 +$0.68 (2.17%) Close

$IMCR Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Company Executives

$IMCR Management Team

Dr. Bahija Jallal

Chief Executive Officer

Executive Director

Age 63

Compensation $12.85M USD

Sex Female

Mr. Travis Coy

Chief Financial Officer and Head of Corporate Development

Age 44

Compensation -

Sex Male

Dr. David Berman

Head of Research and Development

Age 54

Compensation $5.481M USD

Sex Male

Prof. John Bell

Independent Chairman of the Board

Age 72

Compensation $98.53K USD

Sex Male

Mr. Clayton Robertson

Head of Investor Relations

Age -

Compensation -

Sex Male

Name / Title	Age	Compensation	Sex
Dr. Bahija Jallal Chief Executive Officer Executive Director	63	$12.85M USD	Female
Mr. Travis Coy Chief Financial Officer and Head of Corporate Development	44	-	Male
Dr. David Berman Head of Research and Development	54	$5.481M USD	Male
Prof. John Bell Independent Chairman of the Board	72	$98.53K USD	Male
Mr. Clayton Robertson Head of Investor Relations	-	-	Male

Board of Directors

From the proxy statement filed Apr 16, 2026

Directors

serving now

Independent

6 of 7

stated in the proxy

Average tenure

4.7 years

from year joined

CEO also chairs the board

Not stated

no chair stated

Director	Age	On board	Independent	Committees	Other public boards	2025 pay
Siddharth Kaul	Not stated	2022 4 years	Independent	Audit · Chair	None stated	$477,491
William Pao	Not stated	2025 1 year	Independent	Audit	Alentis Therapeutics, AG	Not stated
Kristine Peterson	Not stated	2017 9 years	Independent	None stated	ArriVent BioPharma, Enanta Pharmaceuticals	$472,532
Bahija Jallal	Not stated	Not stated	Not independent	None stated	None stated	Not stated
John Bell	Not stated	Not stated	Independent	None stated	None stated	Not stated
Roy S. Herbst	Not stated	Not stated	Independent	None stated	None stated	Not stated
Peter Ratcliffe	Not stated	Not stated	Independent	Audit	None stated	Not stated

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No related-party transactions disclosed

The proxy filed Apr 16, 2026 describes a review policy but reports no transactions.

Read the policy in the proxy

Comments

Company Executives

$IMCR Management Team

Dr. Bahija Jallal

Mr. Travis Coy

Dr. David Berman

Prof. John Bell

Mr. Clayton Robertson

Board of Directors

Related-party transactions

No related-party transactions disclosed